Anapa Biotech is developing a technology that will significantly improve molecular diagnostics in the near future.
Anapa Biotech is a biotech company founded on research of nucleic acid analogues performed at The University of Southern Denmark and Hvidovre Hospital.
Anapa Biotech develops molecular diagnostic tools for application within i.e. microbiology and cancer. The diagnostic systems improve the existing diagnostic methods by increasing specifity as well as sensivity and by reducing the analysis period. The technology applied ensures a remarkable improvement of hybridization as well as PCR based assays.